Breast-Cancer Drug
Wins FDA Approval

By

Jennifer Corbett Dooren

Updated March 14, 2007 12:01 a.m. ET

WASHINGTON -- The Food and Drug Administration approved Tykerb, a new drug from GlaxoSmithKline PLC to treat advanced breast cancer.

The drug is approved for use in combination with Roche Holding AG's Xeloda in women with a certain type of breast cancer who haven't responded to prior treatment with other drugs, including Genentech Inc.'s...